메뉴 건너뛰기




Volumn 8, Issue 1, 2014, Pages 117-122

All-trans retinoic acid enhances the effect of 5-aza-2′-deoxycytidine on p16INK4a demethylation, and the two drugs synergistically activate retinoic acid receptor β gene expression in the human erythroleukemia K562 cell line

Author keywords

5 aza 2 deoxycytidine; All trans retinoic acid; DNA methylation; K562 cells; P16INK4a; Retinoic acid receptor

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CD11B ANTIGEN; CD33 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; MICROSOMAL AMINOPEPTIDASE; RETINOIC ACID; RETINOIC ACID RECEPTOR BETA;

EID: 84901237166     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2133     Document Type: Article
Times cited : (10)

References (17)
  • 1
    • 0029976873 scopus 로고    scopus 로고
    • Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis
    • Issa J, Vertino PM, Boehm CD, et al: Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc Natl Acad Sci USA 93: 11757-11762, 1996.
    • (1996) Proc Natl Acad Sci USA , vol.93 , pp. 11757-11762
    • Issa, J.1    Vertino, P.M.2    Boehm, C.D.3
  • 2
    • 0036387011 scopus 로고    scopus 로고
    • DNA methylation changes in leukaemia
    • Melki JR and Clark SJ: DNA methylation changes in leukaemia. Semin Cancer Biol 12: 347-357, 2002.
    • (2002) Semin Cancer Biol , vol.12 , pp. 347-357
    • Melki, J.R.1    Clark, S.J.2
  • 3
    • 0035510088 scopus 로고    scopus 로고
    • Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer
    • Takai D, Gonzales FA, Tsai YC, et al: Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. Hum Mol Genet 10: 2619-2626, 2001.
    • (2001) Hum Mol Genet , vol.10 , pp. 2619-2626
    • Takai, D.1    Gonzales, F.A.2    Tsai, Y.C.3
  • 4
    • 62849104641 scopus 로고    scopus 로고
    • Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: A randomised, open-label, phase III study
    • International Vidaza High-Risk MDS Survival Study Group
    • Fenaux P, Mufti GJ, Hellstrom-Lindberg E, et al; International Vidaza High-Risk MDS Survival Study Group: Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol 10: 223-232, 2009.
    • (2009) Lancet Oncol , vol.10 , pp. 223-232
    • Fenaux, P.1    Mufti, G.J.2    Hellstrom-Lindberg, E.3
  • 5
    • 68949145132 scopus 로고    scopus 로고
    • Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: The alternative dosing for outpatient treatment (ADOPT) trial
    • Steensma DP, Baer MR, Slack JL, et al: Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial. J Clin Oncol 27: 3842-3848, 2009.
    • (2009) J Clin Oncol , vol.27 , pp. 3842-3848
    • Steensma, D.P.1    Baer, M.R.2    Slack, J.L.3
  • 6
    • 68049120458 scopus 로고    scopus 로고
    • Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes
    • Voso MT, Santini V, Finelli C, et al: Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. Clin Cancer Res 15: 5002-5007, 2009.
    • (2009) Clin Cancer Res , vol.15 , pp. 5002-5007
    • Voso, M.T.1    Santini, V.2    Finelli, C.3
  • 7
    • 0029011539 scopus 로고
    • 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
    • Merlo A, Herman JG, Mao L, et al: 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1: 686-692, 1995.
    • (1995) Nat Med , vol.1 , pp. 686-692
    • Merlo, A.1    Herman, J.G.2    Mao, L.3
  • 8
    • 0030046322 scopus 로고    scopus 로고
    • Hypermeth-ylation-associated inactivation indicates a tumor suppressor role for p15INK4B
    • Herman JG, Jen J, Merlo A and Baylin SB: Hypermeth-ylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res 56: 722-727, 1996.
    • (1996) Cancer Res , vol.56 , pp. 722-727
    • Herman, J.G.1    Jen, J.2    Merlo, A.3    Baylin, S.B.4
  • 9
    • 0031731906 scopus 로고    scopus 로고
    • Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells
    • Côté S, Sinnett D and Momparler RL: Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells. Anticancer Drugs 9: 743-750, 1998.
    • (1998) Anticancer Drugs , vol.9 , pp. 743-750
    • Côté, S.1    Sinnett, D.2    Momparler, R.L.3
  • 10
    • 0001679798 scopus 로고
    • Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid
    • Breitman TR, Selonick SE and Collins SJ: Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77: 2936-2940, 1980.
    • (1980) Proc Natl Acad Sci USA , vol.77 , pp. 2936-2940
    • Breitman, T.R.1    Selonick, S.E.2    Collins, S.J.3
  • 11
    • 0019310229 scopus 로고
    • Induction of differentiation of cultured human promyelocytic leukemia cells by retinoids
    • Honma Y, Takenaga K, Kasukabe T and Hozumi M: Induction of differentiation of cultured human promyelocytic leukemia cells by retinoids. Biochem Biophys Res Commun 95: 507-512, 1980.
    • (1980) Biochem Biophys Res Commun , vol.95 , pp. 507-512
    • Honma, Y.1    Takenaga, K.2    Kasukabe, T.3    Hozumi, M.4
  • 12
    • 0022404250 scopus 로고
    • Induction of differentiation and inhibition of DNA methylation in HL-60 myeloid leukemic cells by 5-AZA-2'-deoxycytidine
    • Momparler RL, Bouchard J and Samson J: Induction of differentiation and inhibition of DNA methylation in HL-60 myeloid leukemic cells by 5-AZA-2'-deoxycytidine. Leuk Res 9: 1361-1366, 1985.
    • (1985) Leuk Res , vol.9 , pp. 1361-1366
    • Momparler, R.L.1    Bouchard, J.2    Samson, J.3
  • 13
    • 27744545241 scopus 로고    scopus 로고
    • 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells
    • Liu Z, Zhang L, Ding F, et al: 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells. Cancer Lett 230: 271-283, 2005.
    • (2005) Cancer Lett , vol.230 , pp. 271-283
    • Liu, Z.1    Zhang, L.2    Ding, F.3
  • 14
    • 56349137374 scopus 로고    scopus 로고
    • Retinoic acid receptor beta2 re-expression and growth inhibition in thyroid carcinoma cell lines after 5-aza-2'treatment
    • Miasaki FY, Vivaldi A, Ciampi R, et al: Retinoic acid receptor beta2 re-expression and growth inhibition in thyroid carcinoma cell lines after 5-aza-2'treatment. J Endocrinol Invest 31: 724-730, 2008.
    • (2008) J Endocrinol Invest , vol.31 , pp. 724-730
    • Miasaki, F.Y.1    Vivaldi, A.2    Ciampi, R.3
  • 15
    • 84859817127 scopus 로고    scopus 로고
    • The differentiating and apoptotic effects of 2-aza-5'-deoxycytidine are dependent on the PU.1 expression level in PU.1-transgenic K562 cells
    • Aoyama S, Nakano H, Danbara M, et al: The differentiating and apoptotic effects of 2-aza-5'-deoxycytidine are dependent on the PU.1 expression level in PU.1-transgenic K562 cells. Biochem Biophys Res Commun 420: 775-781, 2012.
    • (2012) Biochem Biophys Res Commun , vol.420 , pp. 775-781
    • Aoyama, S.1    Nakano, H.2    Danbara, M.3
  • 16
    • 0031025368 scopus 로고    scopus 로고
    • Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies
    • Herman JG, Civin CI, Issa JP, et al: Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res 57: 837-841, 1997.
    • (1997) Cancer Res , vol.57 , pp. 837-841
    • Herman, J.G.1    Civin, C.I.2    Issa, J.P.3
  • 17
    • 80053122382 scopus 로고    scopus 로고
    • Azacitidine induces demethylation of p16INK4a and inhibits growth in adult T-cell leukemia/lymphoma
    • Uenogawa K, Hatta Y, Arima N, et al: Azacitidine induces demethylation of p16INK4a and inhibits growth in adult T-cell leukemia/lymphoma. Int J Mol Med 28: 835-839, 2011.
    • (2011) Int J Mol Med , vol.28 , pp. 835-839
    • Uenogawa, K.1    Hatta, Y.2    Arima, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.